The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets
- PMID: 17714558
- DOI: 10.1111/j.1365-2133.2007.08137.x
The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets
Abstract
Background: Plasmacytoid dendritic cells and type I interferons (IFNs) are supposed to play a central proinflammatory role in the pathogenesis of cutaneous lupus erythematosus (LE). The IFN-inducible chemokines CXCL9 and CXCL10 are involved in recruiting CXCR3+ effector lymphocytes from the peripheral blood into skin lesions of LE. We hypothesized that the expression pattern of IFN-inducible proteins reflects the characteristic distribution of the inflammatory infiltrate in different subsets of cutaneous LE.
Objectives: To test this hypothesis in patients with LE.
Methods: Lesional skin biopsies taken from patients with different subsets of LE [chronic discoid LE (CDLE), n = 12; subacute cutaneous LE (SCLE), n = 5; LE tumidus (LET), n = 4; LE profundus (LEP), n = 6] were investigated by immunohistochemistry using monoclonal antibodies to the lymphocyte surface markers CD3, CD4, CD8, CD20 and CD68, the cytotoxic proteins Tia1 and granzyme B, the chemokine receptor CXCR3, the specifically type I IFN-inducible protein myxovirus protein A (MxA) and the chemokines CXCL9 and CXCL10.
Results: The expression pattern of MxA followed the distribution of the inflammatory infiltrate typically seen in the investigated cutaneous LE subsets. In CDLE and SCLE, expression was focused in the epidermis and upper dermis, while in LET a perivascular and in LEP a subcutaneous pattern was found. Similar findings were obtained for CXCL9 and CXCL10.
Conclusions: Our results demonstrate a close morphological association between the expression pattern of IFN-inducible proteins and the distribution of CXCR3+ CD3+ lymphocytes in all investigated subsets of cutaneous LE. This supports the importance of an IFN-driven inflammation in this condition. Infiltrating lymphocytes carrying CXCL10 in their granules might amplify the lesional inflammation and be responsible for the chronic course of this disease.
Similar articles
-
Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus.J Pathol. 2005 Mar;205(4):435-42. doi: 10.1002/path.1721. J Pathol. 2005. PMID: 15685590
-
CXCR3-mediated recruitment of cytotoxic lymphocytes in lupus erythematosus profundus.J Am Acad Dermatol. 2007 Apr;56(4):648-50. doi: 10.1016/j.jaad.2006.08.014. J Am Acad Dermatol. 2007. PMID: 17367614
-
CXCR3 <-> ligand-mediated skin inflammation in cutaneous lichenoid graft-versus-host disease.J Am Acad Dermatol. 2008 Mar;58(3):437-42. doi: 10.1016/j.jaad.2007.10.647. J Am Acad Dermatol. 2008. PMID: 18280341
-
Type I interferon-associated cytotoxic inflammation in cutaneous lupus erythematosus.Arch Dermatol Res. 2009 Jan;301(1):83-6. doi: 10.1007/s00403-008-0892-8. Epub 2008 Sep 11. Arch Dermatol Res. 2009. PMID: 18784932 Review.
-
Identification of type I interferon-associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches.Exp Dermatol. 2007 May;16(5):454-63. doi: 10.1111/j.1600-0625.2007.00556.x. Exp Dermatol. 2007. PMID: 17437489 Review.
Cited by
-
Spatial characterization of interface dermatitis in cutaneous lupus reveals novel chemokine ligand-receptor pairs that drive disease.bioRxiv [Preprint]. 2024 Jan 6:2024.01.05.574422. doi: 10.1101/2024.01.05.574422. bioRxiv. 2024. PMID: 38260617 Free PMC article. Preprint.
-
Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions.Am J Clin Dermatol. 2023 Jul;24(4):521-540. doi: 10.1007/s40257-023-00774-8. Epub 2023 May 4. Am J Clin Dermatol. 2023. PMID: 37140884 Free PMC article. Review.
-
Current Knowledge of the Molecular Pathogenesis of Cutaneous Lupus Erythematosus.J Clin Med. 2023 Jan 27;12(3):987. doi: 10.3390/jcm12030987. J Clin Med. 2023. PMID: 36769633 Free PMC article. Review.
-
Characterization of B cells in lupus erythematosus skin biopsies in the context of different immune cell infiltration patterns.Front Med (Lausanne). 2022 Nov 10;9:1037408. doi: 10.3389/fmed.2022.1037408. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36438026 Free PMC article.
-
Identification of Significant Genes and Pathways for the Chronic and Subacute Cutaneous Lupus Erythematosus via Bioinformatics Analysis.Dis Markers. 2022 Sep 29;2022:9891299. doi: 10.1155/2022/9891299. eCollection 2022. Dis Markers. 2022. PMID: 36212172 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
